Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine for pain control after CABG surgery
IRCT20201220049774N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Tizanidine with Placebo (2 arms). Primary endpoint: Severity of postoperative pain. Started Feb 2021; status: completed.
02
Drugs
tizanidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20201220049774N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201220049774N1.